IL17A and necrotizing enterocolitis: Additionally, dysregulation of IL‐17A is hypothesized to be a driver for the inflammation in NEC (Lawrence et al., 2018), and thus IL‐17A has been considered a target of interest in this disease process (Wynn et al., 2016; Fauny et al., 2020).